Evidence map›Paper›PMID 29440378›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Pathology after

Rebeccah S Lijek, Jennifer D Helble, Andrew J Olive, Kyra W Seiger, Michael N Starnbach

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 58 citations in OpenAlex.

  1. Plasmid-encoded Pgp3 protein enhances the infectivity ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  2. Article
  3. CXCR6 marks polyfunctional effector CD4 T cells required for anti-bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. CD8iScience · 2026
    Article
  7. Review
  8. Complete deletion of theInfection and immunity · 2025
    Article
  9. Article
  10. Article
  11. Pathogenic and Protective Roles of Neutrophils inPathogens (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Viral Vector-BasedVaccines · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Insights into innate immune cell evasion byFrontiers in immunology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rebeccah S LijekDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; starnbach@hms.harvard.edu rlijek@mtholyoke.edu.
Jennifer D HelbleDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Andrew J OliveDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115.
Kyra W SeigerDepartment of Biological Sciences, Mount Holyoke College, South Hadley, MA 01075.
Michael N StarnbachDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; starnbach@hms.harvard.edu rlijek@mtholyoke.edu.
Harvard University · USMount Holyoke College · USUniversity of Massachusetts Chan Medical School · US

Funding

Cytotoxic T Cell Mediated Immunity to ChlamydiaR01AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 2001 to 2025
$15.6M
The EPI-STI Biostatistics and Bioinformatics Core (Cuzick/Wheeler)U19AI113187 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WHEELER, COSETTE MARIE · 2014 to 2018
$12.6M
Genetics of Host Resistance to Chlamydia trachomatisR01AI062827 · NIAID · HARVARD MEDICAL SCHOOL · PI STARNBACH, MICHAEL N · 2006 to 2014
$3.8M
Interrogating the Cellular Mechanisms of Host-Pathogen Interactions during IBDF32AI108144 · NIAID · HARVARD MEDICAL SCHOOL · PI LIJEK, REBECCAH · 2014 to 2016
$164k
CYTOTOXIC T CELL MEDIATED IMMUNITY TO CHLAMYDIAR29AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 1996 to 2000
$135k
NIAID NIH HHS F32 AI108144NIAID NIH HHS R01 AI039558NIAID NIH HHS R01 AI062827NIAID NIH HHS R29 AI039558NIAID NIH HHS U19 AI113187
6 · The paper itself

Abstract

Infection with

Indexed as

AnimalsChlamydia InfectionsChlamydia trachomatisFemaleGenitalia, FemaleMiceMonocytesNeutrophilsT-LymphocytesChlamydiaCXCR3infectionneutrophilspathology

Identifiers

PMID29440378
PMCPMC5834673
OpenAlexW2792341545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.